Raia Drogasil S.A.
RADLY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $39 | $34 | $29 | $24 |
| % Growth | 14.4% | 16.9% | 20.5% | – |
| Cost of Goods Sold | $27 | $24 | $20 | $17 |
| Gross Profit | $12 | $10 | $9 | $7 |
| % Margin | 29.7% | 30% | 30.3% | 29.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $2 | $2 | $1 | $1 |
| SG&A Expenses | $9 | $8 | $7 | $6 |
| Sales & Mktg Exp. | $8 | $7 | $6 | $5 |
| Other Operating Expenses | -$0 | -$0 | $0 | $0 |
| Operating Expenses | $9 | $8 | $7 | $6 |
| Operating Income | $2 | $2 | $1 | $1 |
| % Margin | 6.1% | 6.1% | 5.1% | 5.1% |
| Other Income/Exp. Net | -$1 | -$1 | -$1 | -$0 |
| Pre-Tax Income | $1 | $1 | $1 | $1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $1 | $1 | $1 | $1 |
| % Margin | 3.1% | 3.1% | 3.4% | 3.1% |
| EPS | 0.73 | 0.62 | 0.58 | 0.44 |
| % Growth | 17.7% | 6.9% | 31.8% | – |
| EPS Diluted | 0.72 | 0.62 | 0.58 | 0.44 |
| Weighted Avg Shares Out | 2 | 2 | 2 | 2 |
| Weighted Avg Shares Out Dil | 2 | 2 | 2 | 2 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | $3 | $3 | $2 | $3 |
| % Margin | 8.1% | 8.1% | 8.4% | 10.9% |